oseltamivir has been researched along with Infections, Staphylococcal in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Amaro, R; Bassetti, M; Cilloniz, C; Giacobbe, DR; Graziano, E; Russo, A; Soriano, A; Torres, A; Vena, A | 1 |
Gao, J; Li, D; Xia, H; Xiu, M | 1 |
Cleghorn, S | 1 |
Aljefri, D; Avedissian, SN; Cruce, CE; Liu, J; Martin, D; Pais, G; Postelnick, MJ; Rhodes, NJ; Scheetz, MH; Sutton, SH; Zembower, TR | 1 |
Sepkowitz, KA | 1 |
Fasanello, J; Hereth, J; Sharp, JK | 1 |
6 other study(ies) available for oseltamivir and Infections, Staphylococcal
Article | Year |
---|---|
Ceftaroline for severe community-acquired pneumonia: A real-world two-centre experience in Italy and Spain.
Topics: Aged; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Female; Humans; Italy; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oseltamivir; Pneumococcal Infections; Pneumonia; Retrospective Studies; Spain; Staphylococcal Infections; Streptococcus pneumoniae | 2020 |
Community-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus in a Chinese adult: A case report.
Topics: Aged; Anti-Bacterial Agents; Cough; Healthcare-Associated Pneumonia; Humans; Hypokinesia; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Mezlocillin; Oseltamivir; Shock, Septic; Staphylococcal Infections | 2020 |
Highlights from IDWeek 2017.
Topics: Anti-Bacterial Agents; Antiviral Agents; Bacteremia; beta-Lactamases; Clostridioides difficile; Cystitis; Drinking; Drug Administration Schedule; Dysbiosis; Humans; Influenza Vaccines; Influenza, Human; Oseltamivir; Respiratory Tract Infections; Staphylococcal Infections | 2017 |
Understanding the Components, Calculation, and Impact of Monthly and Seasonal Variation of the Standardized Antimicrobial Utilization Ratio (SAAR).
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Azithromycin; Humans; Inappropriate Prescribing; Length of Stay; Methicillin-Resistant Staphylococcus aureus; Oseltamivir; Retrospective Studies; Seasons; Staphylococcal Infections | 2019 |
Forever unprepared--the predictable unpredictability of pathogens.
Topics: Animals; Anti-Bacterial Agents; Birds; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza in Birds; Influenza, Human; Methicillin-Resistant Staphylococcus aureus; Oseltamivir; Staphylococcal Infections; Unnecessary Procedures | 2009 |
Bronchoscopic findings in a child with pandemic novel H1N1 influenza A and methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bronchoscopy; Child; Fatal Outcome; Female; Fibrinolytic Agents; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lung; Meropenem; Methicillin-Resistant Staphylococcus aureus; Oseltamivir; Respiratory Distress Syndrome; Respiratory Insufficiency; Staphylococcal Infections; Thienamycins; Tissue Plasminogen Activator; Vancomycin | 2011 |